Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

Panelists discuss potential changes to clinical pathways for Bruton tyrosine kinase (BTK) inhibitor therapies as a result of ...

Panelists discuss the specific challenges and barriers clinicians might encounter when utilizing different BTK inhibitors ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

As clinician shortages grow, hospitals turn to artificial intelligence (AI) and scheduling tools to optimize resources, ...

A panelist discusses the latest advancements presented at ASCO 2025, highlighting talquetamab’s pivotal trial in relapsed/refractory multiple myeloma that demonstrated high response rates and longer ...

A prior settlement of $6 billion was rejected because it would have shielded the Sacklers from lawsuits even from parties who ...

Pediatric patients with hidradenitis suppurativa have a significantly increased prevalence of chronic medical and psychiatric ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

A global surge in rheumatoid arthritis with local hotspots highlights the need for targeted public health interventions.

B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City, reflects on how the reality of COVID-19 infection proved far more complex than ...